Form 8-K - Current report:
SEC Accession No. 0001640334-21-001457
Filing Date
2021-06-30
Accepted
2021-06-30 16:49:25
Documents
1
Period of Report
2021-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 29607
  Complete submission text file 0001640334-21-001457.txt   31003
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 211062524
SIC: 2834 Pharmaceutical Preparations